|
1
|
Gottardo F, Liu CG, Ferracin M, et al:
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chow TF, Youssef YM, Lianidou E, et al:
Differential expression profiling of microRNAs and their potential
involvement in renal cell carcinoma pathogenesis. Clin Biochem.
43:150–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yi ZJ, Fu YR, Zhao SS, et al: Differential
expression of miRNA patterns in renal cell carcinoma and
nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ljungberg B, Cowan NC, Hanbury DC, et al:
EAU guidelines on renal cell carcinoma: the 2010 update. Euro
Urology. 58:398–406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Janzen NK, Kim HL, Figlin RA, et al:
Surveillance after radical or partial nephrectomy for localized
renal cell carcinoma and management of recurrent disease. Urologic
Clinics of North America. 30:843–852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kondo K, Yao M, Yoshida M, et al:
Comprehensive mutational analysis of the VHL gene in sporadic renal
cell carcinoma: relationship to clinicopathological parameters.
Genes, Chromosomes and Cancer. 34:58–68. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maxwell PH, Wiesener MS, Chang GW, et al:
The tumour suppressor protein VHL targets hypoxia-inducible factors
for oxygen-dependent proteolysis. Nature. 399:271–275. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dalgliesh GL, Furge K, Greenman C, et al:
Systematic sequencing of renal carcinoma reveals inactivation of
histone modifying genes. Nature. 463:360–363. 2010. View Article : Google Scholar
|
|
10
|
Varela I, Tarpey P, Raine K, et al: Exome
sequencing identifies frequent mutation of the SWI/SNF complex gene
PBRM1 in renal carcinoma. Nature. 469:539–542. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fiorito E, Katika MR and Hurtado A:
Cooperating transcription factors mediate the function of estrogen
receptor. Chromosoma. 122:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Musgrove EA and Sutherland RL: Biological
determinants of endocrine resistance in breast cancer. Nat Rev
Cancer. 9:631–643. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harigopal M, Heymann J, Ghosh S,
Anagnostou V, Camp RL and Rimm DL: Estrogen receptor co-activator
(AIB1) protein expression by automated quantitative analysis (AQUA)
in a breast cancer tissue microarray and association with patient
outcome. Breast Cancer Res Treat. 115:77–85. 2009. View Article : Google Scholar
|
|
14
|
Ross-Innes CS, Stark R, Teschendorff AE,
et al: Differential oestrogen receptor binding is associated with
clinical outcome in breast cancer. Nature. 481:389–393.
2012.PubMed/NCBI
|
|
15
|
Ross-Innes CS, Stark R, Holmes KA, et al:
Cooperative interaction between retinoic acid receptor-alpha and
estrogen receptor in breast cancer. Genes Dev. 24:171–182. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grober OM, Mutarelli M, Giurato G, et al:
Global analysis of estrogen receptor beta binding to breast cancer
cell genome reveals an extensive interplay with estrogen receptor
alpha for target gene regulation. BMC Genomics. 12:362011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan MH, Wong CF, Tan HL, et al: Genomic
expression and single-nucleotide polymorphism profiling
discriminates chromophobe renal cell carcinoma and oncocytoma. BMC
Cancer. 10:1962010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gentleman RC, Carey VJ, Bates DM, et al:
Bioconductor: open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schwender H, Krause A and Ickstadt K:
Identifying interesting genes with siggenes [J]. The Newsletter of
the R Project. 6:45–50. 2006.
|
|
20
|
Dennis G Jr, Sherman BT, Hosack DA, et al:
DAVID: Database for annotation, visualization, and integrated
discovery. Genome Biol. 4:P32003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujita PA, Rhead B, Zweig AS, et al: The
UCSC genome browser database: update 2011. Nucleic Acids Res.
39:D876–D882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shannon P, Markiel A, Ozier O, et al:
Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Res. 13:2498–2504. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng Q and Wang XJ: GOEAST: a web-based
software toolkit for Gene Ontology enrichment analysis. Nucleic
Acids Res. 36:W358–W363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen M, Chen LM, Lin CY and Chai KX: The
epidermal growth factor receptor (EGFR) is proteolytically modified
by the Matriptase-Prostasin serine protease cascade in cultured
epithelial cells. BBA-Mol Cell Res. 1783:896–903. 2008.
|
|
25
|
Chen M, Fu YY, Lin CY, Chen LM and Chai
KX: Prostasin induces protease-dependent and independent molecular
changes in the human prostate carcinoma cell line PC-3. Bioch
Biophys Acta. 1773:1133–1140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen LM, Verity NJ and Chai KX: Loss of
prostasin (PRSS8) in human bladder transitional cell carcinoma cell
lines is associated with epithelial-mesenchymal transition (EMT).
BMC Cancer. 9:3772009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sakashita K, Mimori K, Tanaka F, et al:
Clinical significance of low expression of Prostasin mRNA in human
gastric cancer. J Surg Oncol. 98:559–564. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen LM, Zhang X and Chai KX: Regulation
of prostasin expression and function in the prostate. Prostate.
59:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu Y, Brännström M, Janson PO, et al:
Differences in expression patterns of the tight junction proteins,
claudin 1, 3, 4 and 5, in human ovarian surface epithelium as
compared to epithelia in inclusion cysts and epithelial ovarian
tumours. Int J cancer. 118:1884–1891. 2006. View Article : Google Scholar
|
|
30
|
Usami Y, Chiba H, Nakayama F, et al:
Reduced expression of claudin-7 correlates with invasion and
metastasis in squamous cell carcinoma of the esophagus. Hum Pathol.
37:569–577. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tassi RA, Bignotti E, Falchetti M, et al:
Claudin-7 expression in human epithelial ovarian cancer. Int J
Gynecol Cancer. 18:1262–1271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lioni M, Brafford P, Andl C, et al:
Dysregulation of claudin-7 leads to loss of E-cadherin expression
and the increased invasion of esophageal squamous cell carcinoma
cells. Am J Pathol. 170:709–721. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng KW, Lahad JP, Kuo WL, et al: The
RAB25 small GTPase determines aggressiveness of ovarian and breast
cancers. Nat Med. 10:1251–1256. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Calhoun BC and Goldenring J: Rab proteins
in gastric parietal cells: evidence for the membrane recycling
hypothesis. Yale J Biol Med. 69:1–8. 1996.PubMed/NCBI
|
|
35
|
Cheng JM, Volk L, Janaki DK, Vyakaranam S,
Ran S and Rao KA: Tumor suppressor function of Rab25 in
triple-negative breast cancer. Int J Cancer. 126:2799–2812.
2010.PubMed/NCBI
|
|
36
|
Cheng KW, Agarwal R, Mitra S, et al: Rab25
increases cellular ATP and glycogen stores protecting cancer cells
from bioenergetic stress. EMBO Mol Med. 4:125–141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dozynkiewicz MA, Jamieson NB, MacPherson
I, et al: Rab25 and CLIC3 collaborate to promote integrin recycling
from late endosomes/lysosomes and drive cancer progression. Dev
Cell. 22(1): 131–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Amornphimoltham P, Rechache K, Thompson J,
et al: Rab25 regulates invasion and metastasis in head and neck
cancer. Clin Cancer Res. 19:1375–1388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lappano R and Maggiolini M: G
protein-coupled receptors: novel targets for drug discovery in
cancer. Nat Rev Drug Discov. 10:47–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mócsai A, Ruland J and Tybulewicz VL: The
SYK tyrosine kinase: a crucial player in diverse biological
functions. Nat Rev Immunol. 10:387–402. 2010.PubMed/NCBI
|
|
41
|
Sun T, Aceto N, Meerbrey KL, et al:
Activation of multiple proto-oncogenic tyrosine kinases in breast
cancer via loss of the PTPN12 phosphatase. Cell. 144:703–718. 2011.
View Article : Google Scholar : PubMed/NCBI
|
